Tyra Biosciences, Inc. (TYRA)
Nasdaq: TYRA · Pharmaceutical Preparations · Carlsbad, CA · filing with the SEC since 2021
Who runs Tyra Biosciences, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Harris Todd
President and CEO. First filing Sep 2021, latest Sep 17, 2026, 13 filings in all.
Officers reporting now
6
of 19 people with a filing in the last fifteen months
Directors reporting now
13
31 people on the record since 2021
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Harris Todd | President and CEO | Sep 2021 | Sep 17, 2026 | none |
| Rueb Yuliya | Vice President, Finance (PAO) | Apr 2026 | Sep 17, 2026 | none |
| Fuhrman Alan | Chief Financial Officer | Jan 2023 | Sep 17, 2026 | none |
| Ashar Bhavesh | Chief Operating Officer | Dec 2025 | May 7, 2026 | none |
| Warner Douglas J | Chief Medical Officer | Sep 2024 | May 7, 2026 | none |
| Bensen Daniel | Chief Discovery Officer | Sep 2021 | Feb 13, 2026 | 11 · $4.8M |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Kolchinsky Peter | director | Sep 2021 | Sep 17, 2026 | none |
| Ra Capital Healthcare Fund LP | director | Sep 2021 | Sep 17, 2026 | none |
| Ra Capital Management, L.P. | director | Sep 2021 | Sep 17, 2026 | none |
| Ra Capital Nexus Fund, L.P. | director | Sep 2021 | Sep 17, 2026 | none |
| Shah Rajeev M. | director | Sep 2021 | Sep 17, 2026 | none |
| Verjee Rehan | director | Sep 2021 | Sep 11, 2026 | none |
| Gulfo Adele M. | director | Jan 2025 | Jun 1, 2026 | none |
| Moran Susan | director | May 2024 | Jun 1, 2026 | none |
| More Robert J | director | Sep 2021 | Jun 1, 2026 | 2 · $5.2M |
| Rothenberg Stephen Michael | director | May 2024 | Jun 1, 2026 | none |
| Simson Jake | director | Sep 2021 | Jun 1, 2026 | none |
| Dable Habib J | director | Apr 2026 | Apr 20, 2026 | none |
| Kaplan Gilla | director | Sep 2021 | Mar 27, 2026 | 1 · $500,000 |
Earlier names on the record29, newest filing first
Kjellson Nina S · director · last filing Feb 2025Boxer Capital Management, LLC · other · last filing Oct 2024Subramony Siddarth · director · last filing May 2024Tada Hiroomi · officer · last filing Mar 2024Boxer Asset Management Inc. · 10% owner · last filing Feb 2024Boxer Capital, LLC · 10% owner · last filing Feb 2024Davis Aaron I. · 10% owner · last filing Feb 2024Lewis Joseph · 10% owner · last filing Feb 2024Mva Investors, LLC · 10% owner · last filing Feb 2024Chen Isan · director · last filing Jun 2023Patel Piyush R. · officer · last filing Feb 2023Van Den Boom Esther · officer · last filing Sep 2022Hudkins Robert L. · officer · last filing Sep 2022Swanson Ronald V. · officer · last filing Sep 2022Fawaz Ali D. · officer · last filing May 2022Healy John Stephen · officer · last filing Mar 2022Chen Bihua · director · last filing Sep 2021Cormorant Asset Management, LP · 10% owner · last filing Sep 2021Cormorant Global Healthcare Master Fund, LP · 10% owner · last filing Sep 2021Cormorant Private Healthcare Fund III LP · 10% owner · last filing Sep 2021Canaan 2020+ Co-Investment L.P. Series 7 · 10% owner · last filing Sep 2021Canaan Partners 2020+ Co-Investment LLC · 10% owner · last filing Sep 2021Canaan Partners Xi LLC · 10% owner · last filing Sep 2021Canaan Xi L.P. · 10% owner · last filing Sep 2021Alta Partners Nextgen Fund II Management, LLC · 10% owner · last filing Sep 2021Alta Partners Nextgen Fund II, L.P. · 10% owner · last filing Sep 2021Hudson Peter A · 10% owner · last filing Sep 2021Janney Daniel · 10% owner · last filing Sep 2021Mccracken Melissa · director · last filing Sep 2021
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.